Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States

Overview

Journal Am J Psychiatry

Specialty Psychiatry

Date 2017 Sep 27

PMID 28946762

Citations 96

Authors

Mark Olfson

Melanie M Wall

Shang-Min Liu

Carlos Blanco

Affiliations

Soon will be listed here.

Abstract

Objective: The authors sought to determine whether cannabis use is associated with a change in the risk of incident nonmedical prescription opioid use and opioid use disorder at 3-year follow-up.

Method: The authors used logistic regression models to assess prospective associations between cannabis use at wave 1 (2001-2002) and nonmedical prescription opioid use and prescription opioid use disorder at wave 2 (2004-2005) of the National Epidemiologic Survey on Alcohol and Related Conditions. Corresponding analyses were performed among adults with moderate or more severe pain and with nonmedical opioid use at wave 1. Cannabis and prescription opioid use were measured with a structured interview (the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV version). Other covariates included age, sex, race/ethnicity, anxiety or mood disorders, family history of drug, alcohol, and behavioral problems, and, in opioid use disorder analyses, nonmedical opioid use.

Results: In logistic regression models, cannabis use at wave 1 was associated with increased incident nonmedical prescription opioid use (odds ratio=5.78, 95% CI=4.23-7.90) and opioid use disorder (odds ratio=7.76, 95% CI=4.95-12.16) at wave 2. These associations remained significant after adjustment for background characteristics (nonmedical opioid use: adjusted odds ratio=2.62, 95% CI=1.86-3.69; opioid use disorder: adjusted odds ratio=2.18, 95% CI=1.14-4.14). Among adults with pain at wave 1, cannabis use was also associated with increased incident nonmedical opioid use (adjusted odds ratio=2.99, 95% CI=1.63-5.47) at wave 2; it was also associated with increased incident prescription opioid use disorder, although the association fell short of significance (adjusted odds ratio=2.14, 95% CI=0.95-4.83). Among adults with nonmedical opioid use at wave 1, cannabis use was also associated with an increase in nonmedical opioid use (adjusted odds ratio=3.13, 95% CI=1.19-8.23).

Conclusions: Cannabis use appears to increase rather than decrease the risk of developing nonmedical prescription opioid use and opioid use disorder.

Citing Articles

Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning.

Jayawardhana J, Hou J, Freeman P, Talbert J JAMA Psychiatry. 2024; 82(3):228-236.

PMID: 39714863 PMC: 11883495. DOI: 10.1001/jamapsychiatry.2024.4145.

Exploring Algorithmic Explainability: Generating Explainable AI Insights for Personalized Clinical Decision Support Focused on Cannabis Intoxication in Young Adults.

Zhang T, Chung T, Dey A, Bae S 2024 Int Conf Act Behav Comput (2024). 2024; 2024.

PMID: 39600343 PMC: 11586775. DOI: 10.1109/abc61795.2024.10652070.

The role of cannabis on total hip and knee surgeries outcomes: a systematic review and meta-analysis.

Hoveidaei A, Pouramini A, Mousavi-Nasab M, Taghavi P, Miri L, Saggar R Int Orthop. 2024; 49(2):343-355.

PMID: 39562357 DOI: 10.1007/s00264-024-06359-2.

Prevalence and Effect of Cannabinoids in Pain Management for Hand Pathologies.

Sleiman M, Straszewski A, Stepan J, Conti Mica M Hand (N Y). 2024; :15589447241284275.

PMID: 39392237 PMC: 11559846. DOI: 10.1177/15589447241284275.

Preoperative Cannabis Use Did Not Increase Opioid Utilization After Primary Total Knee Arthroplasty in a Propensity Score-Matched Model.

Puri S, Ong C, Chiu Y, Lebowitz J, Sideris A, Gonzalez Della Valle A HSS J. 2024; 20(2):268-273.

PMID: 39281986 PMC: 11393616. DOI: 10.1177/15563316221151158.

References

Grant B, Dawson D, Stinson F, Chou P, Kay W, Pickering R . The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003; 71(1):7-16. DOI: 10.1016/s0376-8716(03)00070-x. View

Blanco C, Alderson D, Ogburn E, Grant B, Nunes E, Hatzenbuehler M . Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007; 90(2-3):252-60. DOI: 10.1016/j.drugalcdep.2007.04.005. View

Abrams D, Couey P, Shade S, Kelly M, Benowitz N . Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011; 90(6):844-51. DOI: 10.1038/clpt.2011.188. View

Tanda G, Pontieri F, Di Chiara G . Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science. 1997; 276(5321):2048-50. DOI: 10.1126/science.276.5321.2048. View

Powell D, Pacula R, Jacobson M . Do medical marijuana laws reduce addictions and deaths related to pain killers?. J Health Econ. 2018; 58:29-42. PMC: 7867411. DOI: 10.1016/j.jhealeco.2017.12.007. View

Hasin D, Grant B . The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol. 2015; 50(11):1609-40. PMC: 4618096. DOI: 10.1007/s00127-015-1088-0. View

Blanco C, Hasin D, Wall M, Florez-Salamanca L, Hoertel N, Wang S . Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry. 2016; 73(4):388-95. DOI: 10.1001/jamapsychiatry.2015.3229. View

Boehnke K, Litinas E, Clauw D . Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain. 2016; 17(6):739-44. DOI: 10.1016/j.jpain.2016.03.002. View

Compton W, Dawson D, Duffy S, Grant B . The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States. Am J Psychiatry. 2010; 167(4):473-4. PMC: 2917586. DOI: 10.1176/appi.ajp.2009.09081087. View

10.

Hazekamp A, Heerdink E . The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. Eur J Clin Pharmacol. 2013; 69(8):1575-80. DOI: 10.1007/s00228-013-1503-y. View

11.

Wilcox H, Wagner F, Anthony J . Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use. Drug Alcohol Depend. 2002; 66(2):127-35. DOI: 10.1016/s0376-8716(01)00191-0. View

12.

Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G . Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl). 2001; 158(3):259-66. DOI: 10.1007/s002130100875. View

13.

Blanco C, Alegria A, Liu S, Secades-Villa R, Sugaya L, Davies C . Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2012; 73(6):865-73. DOI: 10.4088/JCP.10m06673. View

14.

Bachhuber M, Saloner B, Cunningham C, Barry C . Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014; 174(10):1668-73. PMC: 4392651. DOI: 10.1001/jamainternmed.2014.4005. View

15.

Hasin D, Saha T, Kerridge B, Goldstein R, Chou S, Zhang H . Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015; 72(12):1235-42. PMC: 5037576. DOI: 10.1001/jamapsychiatry.2015.1858. View

16.

Hasin D, Carpenter K, McCloud S, Smith M, Grant B . The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997; 44(2-3):133-41. DOI: 10.1016/s0376-8716(97)01332-x. View

17.

Bonn-Miller M, Boden M, Bucossi M, Babson K . Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse. 2013; 40(1):23-30. DOI: 10.3109/00952990.2013.821477. View

18.

Le Strat Y, Le Foll B . Obesity and cannabis use: results from 2 representative national surveys. Am J Epidemiol. 2011; 174(8):929-33. DOI: 10.1093/aje/kwr200. View

19.

Lynskey M, Vink J, Boomsma D . Early onset cannabis use and progression to other drug use in a sample of Dutch twins. Behav Genet. 2006; 36(2):195-200. DOI: 10.1007/s10519-005-9023-x. View

20.

Compton W, Han B, Hughes A, Jones C, Blanco C . Use of Marijuana for Medical Purposes Among Adults in the United States. JAMA. 2016; 317(2):209-211. PMC: 7391484. DOI: 10.1001/jama.2016.18900. View